Stock

Biocon — MTF Book

BIOCON · Biocon Limited
Health Technology

Daily Margin Trading Facility book for Biocon across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Biocon’s MTF book?

Biocon Limited (BIOCON) has ₹122 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.08% of India’s MTF book, ranking #311. Over 1M (the last 30 trading days) the funded value has risen 10.2%, with the number of shares under margin up 15.9%.

Funded value
₹122 Cr
as of 23 Oct 2026
Rank in book
#311
2,248 days tracked
Share of book
0.08%
of the whole NSE + BSE book
Peak funded
₹258 Cr
on 09 May 2024
Largest single-day addition
+₹157 Cr
on 03 Aug 2017
Largest single-day unwind
−₹157 Cr
on 04 Aug 2017
Free-float market cap
₹29,139 Cr
full market cap ₹52,721 Cr · 55.3% free float · Mid cap
MTF share of free float
0.34%
0.8× the median mid cap · 0.4× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.00%0.77%1.54%2.31%Feb 2024Oct 2026
View as table: share of free float on margin33 months
Month-end% of free float
23 Oct 20260.343%
30 Sep 20260.340%
31 Aug 20260.267%
31 Jul 20260.203%
30 Jun 20260.263%
29 May 20260.163%
30 Apr 20260.283%
30 Mar 20260.298%
27 Feb 20260.345%
30 Jan 20260.471%
31 Dec 20250.512%
28 Nov 20250.540%
31 Oct 20250.489%
30 Sep 20250.557%
29 Aug 20250.511%
31 Jul 20250.557%
30 Jun 20250.552%
30 May 20250.465%
30 Apr 20250.446%
28 Mar 20250.300%
28 Feb 20250.424%
31 Jan 20250.535%
31 Dec 20240.634%
29 Nov 20240.809%
31 Oct 20240.988%
30 Sep 20241.287%
30 Aug 20240.976%
31 Jul 20240.973%
28 Jun 20241.090%
31 May 20241.687%
30 Apr 20241.725%
28 Mar 20241.928%
29 Feb 20242.034%

Dated events

NSE & BSE split

How BIOCON’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹117 Cr · 96.1%BSE ₹5 Cr · 3.9%

MTF vs Price

Margin-funded outstanding for BIOCON in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹323.50
as of 23 Oct 2026
Price, 1M
−18.1%
adjusted for splits and bonuses
Delivery, 20-day avg
53.4%
of traded volume actually settled
Sessions to unwind
2
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹2−2.0%−2.0%
−61,649
−2.1%unwinding as it falls
10D+₹1+1.2%+4.3%
+1,28,429
−7.6%building as it falls
1M+₹11+10.2%+15.9%
+4,23,932
−17.5%building as it falls
3M+₹48+66.1%+76.2%
+13,37,068
−25.7%building as it falls
6M+₹14+12.7%+7.4%
+2,14,193
−9.6%building as it falls
1Y+₹5+4.5%−1.9%
−59,077
−10.7%unwinding as it falls

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where BIOCON has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

BIOCON — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 2026122−₹20.08%311
22 Oct 2026124+₹00.08%309
21 Oct 2026124+₹10.08%314
19 Oct 2026124+₹10.08%317
16 Oct 2026122+₹10.08%322
15 Oct 2026121+₹10.08%323
14 Oct 2026120+₹00.08%324
13 Oct 2026120−₹10.08%322
12 Oct 2026121+₹10.08%322
09 Oct 2026120−₹00.08%326
08 Oct 2026120−₹60.08%325
07 Oct 2026126+₹30.08%308
06 Oct 2026124−₹00.08%316
05 Oct 2026124+₹00.08%315
01 Oct 2026123−₹20.08%318
30 Sep 2026125+₹00.08%315
29 Sep 2026125−₹10.08%315
28 Sep 2026126−₹10.08%315
25 Sep 2026126+₹10.08%315
24 Sep 2026125+₹20.08%318
23 Sep 2026123−₹30.08%318
22 Sep 2026126+₹20.08%312
21 Sep 2026125+₹50.08%314
18 Sep 2026120−₹10.08%319
17 Sep 2026121−₹20.08%319
16 Sep 2026123+₹10.08%317
15 Sep 2026122+₹10.08%318
11 Sep 2026122−₹20.08%321
10 Sep 2026123+₹50.08%315
09 Sep 2026119—0.08%326

BIOCON within Health Technology

Ranked #15 of 61 funded Health Technology stocks, carrying 1.8% of that sector’s margin book. Its 0.34% of free float on margin is 0.4× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
13NEULANDLABNeuland Laboratories₹1241.8%0.72%+57.6%
14BLUEJETBlue Jet Healthcare₹1231.8%4.44%−12.4%
15BIOCONBiocon Limited₹1221.8%0.34%+10.2%
16PPLPHARMAPiramal Pharma₹1111.7%0.64%+5.8%
17SHILPAMEDShilpa Medicare₹1061.6%1.44%−22.2%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.